Stereotactic injection of DTI-015 into recurrent malignant gliomas: phase I/II trial. (Record no. 12453209)

MARC details
000 -LEADER
fixed length control field 01586 a2200445 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250514063027.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 200307s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1522-8002
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1016/s1476-5586(03)80012-x
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Hassenbusch, Samuel J
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20030725
245 00 - TITLE STATEMENT
Title Stereotactic injection of DTI-015 into recurrent malignant gliomas: phase I/II trial.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Neoplasia (New York, N.Y.)
Date of publication, distribution, etc.
300 ## - PHYSICAL DESCRIPTION
Extent 9-16 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Clinical Trial; Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adult
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antineoplastic Agents, Alkylating
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Brain Neoplasms
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Carmustine
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Ethanol
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Glioma
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Injections, Intralesional
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Magnetic Resonance Imaging
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Male
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Maximum Tolerated Dose
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Middle Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Neoplasm Recurrence, Local
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Stereotaxic Techniques
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Survival Rate
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Nardone, Emilio M
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Levin, Victor A
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Leeds, Norman
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Pietronigro, Dennis
773 0# - HOST ITEM ENTRY
Title Neoplasia (New York, N.Y.)
Related parts vol. 5
-- no. 1
-- p. 9-16
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1016/s1476-5586(03)80012-x">https://doi.org/10.1016/s1476-5586(03)80012-x</a>
Public note Available from publisher's website

No items available.